Cancer Drug Resistance
All Journals
Search Log In
Editor-in-Chief: Godefridus J. Peters
Indexing: ESCI, PMC, Scopus, CAS, CNKI, Dimensions, Lens, Embase, ASCI,
Journal Rank: 2025 Impact Factor: 7.6 - Q1 (ONCOLOGY); CiteScore 2025: 10.3 - Q1 (Pharmacology)
Median time to first editorial decision: 9 days
Home Articles Special Topics Volumes Webinars Interviews
Cancer Drug Resistance
Search Submit
Editor-in-Chief: Godefridus J. Peters
Journal Rank: 2025 Impact Factor: 7.6 - Q1 (ONCOLOGY); CiteScore 2025: 10.3 - Q1 (Pharmacology)
Median time to first editorial decision: 9 days
Home Articles Special Topics Volumes Webinars Interviews

Cancer Drug Resistance

Mitochondria in colorectal cancer stem cells - a target in drug resistance

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma

P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport

Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance

Targeting regulated cell death pathways in acute myeloid leukemia

Articles

Most Recent | Most Viewed | Most Downloaded

Lack of resolution of inflammation marks malignant pleural mesothelioma progression

Veronica Gatti, ...Vito Michele Fazio
Open Access Original Article DOI: 10.20517/cdr.2026.33 23 Jul 2026
Views: Downloads:
Download PDF

LINC01607 promotes hepatocellular carcinoma progression and ferroptosis-associated therapy resistance with functional involvement of the p62–Keap1–Nrf2 pathway

Yuxin Zhang, ...Yujie Zhang
Open Access Original Article DOI: 10.20517/cdr.2026.02 17 Jul 2026
Views: Downloads:
Download PDF

Unveiling the role of UGT enzymes in chemoresistance: a path to enhanced cancer pharmacotherapy

Gesine Kretzschmar, ...Jakub Hofman
Open Access Original Article DOI: 10.20517/cdr.2026.10 8 Jun 2026
Views: Downloads:
Download PDF

A systematic review and network meta analysis of first-line immunotherapy for advanced urothelial carcinoma

Yang Liu, ...Tao Xu
Open Access Meta-Analysis DOI: 10.20517/cdr.2026.22 5 Jun 2026
Views: Downloads:
Download PDF

Fenretinide in cancer therapy and chemoprevention: past, present and future

Paola Verachi, ...Ann Zeuner
Open Access Review DOI: 10.20517/cdr.2025.210 5 Jun 2026
Views: Downloads:
Download PDF

ALK inhibitors in cancer: mechanisms of resistance and therapeutic management strategies

Darin Poei, ... Robert HsuRobert Hsu
Open Access Review DOI: 10.20517/cdr.2024.25 22 May 2024
Views: Downloads:
Download PDF

NFE2L2 and ferroptosis resistance in cancer therapy

Daolin TangDaolin Tang, Rui Kang
Open Access Review DOI: 10.20517/cdr.2024.123 24 Oct 2024
Views: Downloads:
Download PDF

Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment

Jindong XieJindong Xie, ... Xiaoming Xie
Open Access Review DOI: 10.20517/cdr.2024.152 6 Jan 2025
Views: Downloads:
Download PDF

Coming soon.

For Reviewers

Peer Review Guidelines
For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Themed Collections
Resistance
Drug delivery
Nanomedicine
Tumor microenvironment
Immune checkpoint inhibitors
Target therapy
Immunotherapy
Radiotherapy
Ferroptosis
PARP inhibitors
MYC
ABC transporters
Autophagy
Metabolism
Mechanisms
Precision medicine
Extracellular vesicles
Stem cell
Biomarker
Ovarian cancer
Renal cell carcinoma
Prostate cancer
Breast cancer
Colorectal cancer
Myeloid leukemia
Non-small cell lung cancer
Pancreatic cancer
Head and neck cancer
Squamous cell carcinoma
Mitochondria
Topic: Genomic and Genetic Alterations Associated with Cancer Drug Resistance
Topic: Role of Tumor Microenvironment in Cancer Drug Resistance
Topic: Resistance Challenges of Antibody-Drug Conjugates (ADCs) in Cancer Therapy
Volume 8 (in progress)
Volume 7
Volume 6, Issue 4
Volume 6, Issue 3
Volume 6, Issue 2
Volume 6, Issue 1
Volume 5, Issue 4
Volume 5, Issue 3
Volume 5, Issue 2
Volume 5, Issue 1
Volume 4, Issue 4
Volume 4, Issue 3
Volume 4, Issue 2
Volume 4, Issue 1
Volume 3, Issue 4
Volume 3, Issue 3
Volume 3, Issue 2
Volume 3, Issue 1
Volume 2, Issue 4
Volume 2, Issue 3
Volume 2, Issue 2
Volume 2, Issue 1
Volume 1, Issue 4
Volume 1, Issue 3
Volume 1, Issue 2
Volume 1, Issue 1
Articles Collection
Related Journals

Extracellular Vesicles and Circulating Nucleic Acids

Editor-in-Chief: Yoke Peng Loh

Journal of Cancer Metastasis and Treatment

The Special Collection "Cancer Cell Plasticity in Therapy Resistance" Officially Launched and Open for Submissions
Breaking Resistance, Shaping the Future | Research Voices (Episode 4)
Prof. A. Thomas Look Reflects on Evolutionary Resistance, Transgenic Zebrafish Models, and the Future of Pediatric Oncology
Breaking Resistance, Shaping the Future | Editorial Board Voices (Episode 3)
Prof. Robert van Waardenburg Reflects on Mechanistic Science, Multi-Omics Verification, and the Future of Cancer Therapy Resistance
Breaking Resistance, Shaping the Future | Editorial Board Voices (Episode 2)
Prof. Mario Cioce Reflects on Clinical Bottlenecks, Emerging Models, and the Future of Cancer Therapy Resistance
Editorial Board Voices (Episode 1) - Featuring Editor-in-Chief Prof. Godefridus J. Peters
A new interview series highlighting expert perspectives, scientific innovation, and the future of cancer drug resistance research.
Breaking Resistance, Shaping the Future: Cancer Drug Resistance Launches Its 8th Anniversary Scientific Series with a Special Message from Editor-in-Chief Prof. Godefridus J. Peters
a new scientific initiative designed to foster global dialogue, collaboration, and innovation in cancer drug resistance research.

Mitochondria in colorectal cancer stem cells - a target in drug resistance

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma

P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport

Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance

Targeting regulated cell death pathways in acute myeloid leukemia

ALK inhibitors in cancer: mechanisms of resistance and therapeutic management strategies
Darin Poei, ... Robert HsuRobert Hsu
Open Access | Review | 22 May 2024
Views: | Downloads:
Download PDF
NFE2L2 and ferroptosis resistance in cancer therapy
Daolin TangDaolin Tang, Rui Kang
Open Access | Review | 24 Oct 2024
Views: | Downloads:
Download PDF
Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment
Jindong XieJindong Xie, ... Xiaoming Xie
Open Access | Review | 6 Jan 2025
Views: | Downloads:
Download PDF
Related Journals

Extracellular Vesicles and Circulating Nucleic Acids

Editor-in-Chief: Yoke Peng Loh

Journal of Cancer Metastasis and Treatment

Coming soon.

Volume 8 (in progress)
Volume 7
Volume 6, Issue 4
Volume 6, Issue 3
Volume 6, Issue 2
Volume 6, Issue 1
Volume 5, Issue 4
Volume 5, Issue 3
Volume 5, Issue 2
Volume 5, Issue 1
Volume 4, Issue 4
Volume 4, Issue 3
Volume 4, Issue 2
Volume 4, Issue 1
Volume 3, Issue 4
Volume 3, Issue 3
Volume 3, Issue 2
Volume 3, Issue 1
Volume 2, Issue 4
Volume 2, Issue 3
Volume 2, Issue 2
Volume 2, Issue 1
Volume 1, Issue 4
Volume 1, Issue 3
Volume 1, Issue 2
Volume 1, Issue 1
Articles Collection
Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
Rss
© 2016-2026 OAE Publishing Inc., except certain content provided by third parties